Alzamend Neuro, Inc. Quarterly Costs and Expenses in USD from Q2 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Alzamend Neuro, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2020 to Q1 2023.
  • Alzamend Neuro, Inc. Costs and Expenses for the quarter ending April 30, 2023 was $3.31M, a 14.7% decline year-over-year.
  • Alzamend Neuro, Inc. Costs and Expenses for the twelve months ending April 30, 2023 was $14.9M, a 20.7% increase year-over-year.
  • Alzamend Neuro, Inc. annual Costs and Expenses for 2022 was $14.9M, a 20.7% increase from 2021.
  • Alzamend Neuro, Inc. annual Costs and Expenses for 2021 was $12.3M, a 149% increase from 2020.
  • Alzamend Neuro, Inc. annual Costs and Expenses for 2020 was $4.95M, a 11.9% increase from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $14.9M $3.31M -$568K -14.7% Feb 1, 2023 Apr 30, 2023 10-K 2023-07-27
Q4 2022 $15.4M $5.42M +$2.87M +112% Nov 1, 2022 Jan 31, 2023 10-Q 2023-03-15
Q3 2022 $12.6M $3.11M -$478K -13.3% Aug 1, 2022 Oct 31, 2022 10-Q 2022-12-12
Q2 2022 $13M $3.04M +$729K +31.6% May 1, 2022 Jul 31, 2022 10-Q 2022-09-13
Q1 2022 $12.3M $3.87M +$2.65M +217% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-27
Q4 2021 $9.67M $2.56M +$1.44M +129% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-15
Q3 2021 $8.23M $3.58M +$2.29M +176% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-12
Q2 2021 $5.94M $2.31M +$988K +74.9% May 1, 2021 Jul 31, 2021 10-Q 2022-09-13
Q1 2021 $4.95M $1.22M Feb 1, 2021 Apr 30, 2021 10-K 2022-07-19
Q4 2020 $1.12M Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 $1.3M Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-13
Q2 2020 $1.32M May 1, 2020 Jul 31, 2020 10-Q 2021-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.